Clinical trial
Aripiprazole in the Treatment of Tourette's Syndrome
NCT00282139 · University of Florida, Other · Terminated
Key facts
| NCT number | NCT00282139 |
|---|---|
| Title | Aripiprazole in the Treatment of Tourette's Syndrome |
| Official title | Aripiprazole in the Treatment of Tourette's Syndrome |
| Lead sponsor | University of Florida, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Tourette's Syndrome |
| Intervention type | Drug |
| Interventions | Aripiprazole |
| Enrollment | 40 |
| Start date | Jan 1, 2004 |
| Primary completion | Oct 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Jan 25, 2006 |
| Last update posted | Oct 5, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: